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httpPercutaneous thoracic endovascular aortic repair
for ascending aortic pseudoaneurysm after
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and Madison, Wisc
Ascending aortic pseudoaneurysms are an uncommon and challenging surgical problem that requires intervention to
avoid rupture and hemorrhage. Preceding cardiac procedures often compound the high rate of morbidity and mortality
associated with open repair. A case is described of an iatrogenic pseudoaneurysm in a patient with a recently placed
prosthetic aortic valve and a clinical course precluding repeat open operative procedure. An endovascular approach was
used, with placement of a thoracic aorta endograft with temporary cardiac pacing and a double-curved Lunderquist wire
to avoid instrumenting the prosthetic aortic valve. At 9 months of follow-up, the patient returned to his baseline activity
status, and at 24 months, had no symptoms or signs of infection, and a computed tomography angiogram demonstrated
pseudoaneurysm exclusion with no graft migration. (J Vasc Surg Cases 2015;1:283-6.)The mainstay of treatment for ascending aortic pathol-
ogy is open repair. Cardiothoracic surgeons have long
performed open procedures for ascending aorta aneurysms
and type A aortic dissections, often with repair of concur-
rent aortic valve anomalies (bicuspid and unicuspid valves
with stenosis or insufﬁciency). These procedures require
cardiopulmonary bypass and may be unsuitable for some
patients. Endovascular approaches for ascending aortic pa-
thology have been described more frequently in recent
years, often as case reports or limited case series.1-3 Most
reports of endovascular approaches focus on treatment of
ascending aorta aneurysmal disease as well as type A dissec-
tions, with less attention to other aortic pathology.
Pseudoaneurysms of the ascending aorta are seen in rare
circumstances, typically after cardiac surgery or chest trauma.
The potential for rupture or signiﬁcant hemorrhage man-
dates surgical intervention. However, open operative proce-
dures for aortic pseudoaneurysms carry a high risk of
morbidity, with mortality rates of 41% to 60%.4,5
Endovascular approaches to ascending aortic pseudoa-
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Endograft placement for AAPs has also been described in
case reports9-11; yet, complications such as graft migra-
tion,12 ventricular perforation, or pseudoaneurysm forma-
tion have been reported,3 and technical approaches vary
signiﬁcantly. We discuss a unique case of endograft exclu-
sion of an iatrogenic AAP in a patient with a prosthetic
mechanical aortic valve and the techniques that led to suc-
cessful treatment. The patient presented in this case report
consented to the publication of this information.CASE REPORT
A 60-year-old obese man had undergone a minimally invasive
sternotomy with prosthetic aortic valve replacement. His postoper-
ative course was complicated by a cardiac arrest with mediastinal
bleeding requiring re-exploration. An anterior ascending aorta
injury was found and was repaired primarily. He was discharged
home, but returned 10 days later after a syncopal episode and
fall with recurrent mediastinal bleeding.
Repeat sternal exploration was performed after computed
tomography diagnosed continued anterior aortic bleeding. Puru-
lent ﬂuid was also drained from the pericardium, and cultures
were positive for Escherichia coli and Proteus mirabilis. He was sub-
sequently discharged to a skilled nursing facility but returned in
1 week with wound dehiscence and recurrent bleeding. A sternot-
omy was once again performed, and the site of aortic bleeding was
repaired with biologic glue because the tissue was felt unsuitable
for suture retention. A pectoralis major ﬂap was placed in the
sternal wound bed. Three subsequent sternal site washouts fol-
lowed during the next week, and anticoagulation was held. Unfor-
tunately, he once again became hypotensive, with chest pain and
evidence on examination of active bleeding, and underwent
another mediastinal hematoma evacuation.
The patient was transferred to our hospital on broad-spectrum
antibiotic therapy and concern for continued ascending aorta
bleeding and infection. He arrived with imaging demonstrating283
Fig 1. Infected pseudoaneurysm of anterior ascending aorta is seen on (left) a computed tomography scan and
(right) volume-rendered image.
Fig 2. CTAG (W. L. Gore and Associates., Flagstaff, Ariz) device
placement in the ascending aorta.
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(Fig 1). Multiple cardiothoracic surgeon consultants judged he
was too severely deconditioned to tolerate a repeat open operative
intervention requiring cardiopulmonary bypass and ascending
aortic graft placement. He was managed initially with pharmaco-
logic hypotension and no anticoagulation, despite the prosthetic
aortic valve; however, he had had a recurrent bleeding episode
during medical management.The decision was made to attempt endovascular repair with off-
label endograft use for exclusion of the AAP. This was deemed a
viable option based on a preoperative computed tomography angio-
gram showing the ascending aorta was at least 10 cm long. This was
conﬁrmed with catheter-based angiogram measurements of the
outer wall length; therefore, we chose a 45-mm diameter by 10-
cm length CTAG device (W. L. Gore & Associates, Flagstaff, Ariz).
A multidisciplinary team was organized, consisting of a cardiac
anesthesiologist, echocardiographer, interventional cardiologist,
cardiac surgeon, and vascular surgeons. A temporary pacemaker
was placed to provide rapid ventricular pacing for accurate graft
deployment. Percutaneous catheterization of the right common
femoral artery was performed under ultrasound guidance. A Pros-
tar 10F XL (Abbott, Abbott Park, Ill) device was inserted and
deployed with the preclose technique.
After access into the ascending aorta and placement of a Lun-
derquist double-curved wire (OptiMed, Ettlingen, Germany), a
24F sheath was inserted. Thoracic arch aortography and transeso-
phageal echocardiography showed the prosthetic aortic valve was
intact. The Lunderquist wire was advanced and allowed to deﬂect
off of the valve ring. The prosthetic valve was not crossed, reducing
the possibility of wire entrapment on the valve and decreasing the
risk of damage to the valve leaﬂets.
A pigtail catheter was passed retrograde from the right
brachial artery into the aorta for arch aortography during graft
deployment and to facilitate real-time localization of the innomi-
nate artery at the point where the brachial and transfemoral wires
crossed. A transesophageal echocardiogram was used to conﬁrm
ascending aortic diameter measurements and to precisely locate
the coronary ostia and the innominate artery oriﬁce.
The CTAG device was advanced into position (Fig 2). A
rescue wire was placed from the right brachial artery through the
Fig 3. Device deployment directly distal to prosthetic valve (left) and completion angiogram with patent arch
vasculature (right).
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need for snorkel stent placement. Rapid ventricular pacing was
brieﬂy induced to ensure a high rate of capture, while simultaneous
conﬁrmatory angiography and transesophageal echocardiographic
monitoring was performed with apnea (ventilation held). The
endograft was then deployed directly above the coronary ostia
and at the innominate origin (Fig 3) during rapid pacing, which
lasted for 4 to 5 seconds. A standard frame rate of 3 frames/s
was used throughout the procedure and contrast injection rates
were 15 mL/s for 30 mL (2 seconds). Echocardiographic imaging
allowed real-time evaluation of the coronary arteries to conﬁrm our
positioning, which was based primarily on angiography. The
sheath was withdrawn, and the access site closure was performed
with the closure device.
Postoperatively, the patient was restarted on systemic anticoagu-
lation with heparin. He was extubated on postoperative day 4 and
transferred out of the intensive care unit on postoperative day 11.
He was discharged 22 days after the procedure. Given the placement
of a prosthetic endograft in an infected ﬁeld with Escherichia coli
and Proteus mirabilis returning from cultures, intravenous vanco-
mycin, ceftriaxone, and micafungin were used for a total of 4 weeks.
The patient has been seen in follow-up at 5, 9, 12, and
24 months from surgery with repeat computed tomography. He
has no signs or symptoms of infection, has returned to his usual ac-
tivities, and imaging shows an excluded AAP (Fig 4).
DISCUSSION
Endovascular treatment of ascending aortic pathology is
a novel option. One device speciﬁcally developed for the
ascending aorta has been deployed successfully13; however,
infrarenal and off-label descending thoracic aortic devices
are currently themainstay of endovascular treatment.Case re-
ports and small case series describe treatment of common
ascending aorta pathologies1-3; yet, in patients with more un-
common conditions and complicated anatomy, such as this
patient with an AAP and a prosthetic aortic valve, strategies
for safe device deployment require further exploration.The nuances of endovascular device placement in
ascending aortic pathology are important. Rapid ventricu-
lar pacing is used by some,14 and atrial occlusion for
controlled hypotension is used by others.9 Rapid right ven-
tricular pacing through a pulmonary artery catheter has also
been described.15 Rapid transvenous ventricular pacing is
our preferred method and resulted in adequate ﬂow arrest.
Using this technique, a 10-cm device was landed precisely
between the coronary ostia and the innominate origin.
Techniques to protect previously placed prosthetic aortic
valves while placing an ascending aortic endograft are less well
known and deserve focused attention. Manipulating a large-
caliber endovascular deployment system in the ascending
aorta requires a stiff wire for tracking while in close vicinity
to the aortic valve. Wire entrapment is therefore a major
concern. Techniques to avoid wire entrapment have been
described in the interventional literature, speciﬁcally when
passing across prosthetic valves for left ventricle pressure
measurement.16 Wire entrapment has been reported when
passing through native valves while placing hemodialysis
catheters17,18 and during attempts at paravalvular leak repair
after prosthetic valve placement.19 Ventricular complications,
such as cardiac perforation or ventricular pseudoaneurysm,
have also been reported after endovascular wire manipulation
within the heart.3 In this case, a double-curved Lunderquist
wire provided adequate stiffness while allowing deﬂection
off of the prosthetic valve in a limited working zone. Without
crossing the valve, the chance of wire-related valve dysfunc-
tion and ventricular complications were reduced.
Other techniques used in this case included percuta-
neous access to avoid the sternum and obtaining a second
access for arteriography from the right brachial artery.
Transesophageal echocardiography was essential for
real-time assessment of guidewire location, endograft posi-
tioning, and prosthetic valve function. Careful selection of
a device with an adequate working length and a short
nosecone is necessary. In this case, the short tip of the
Fig 4. Follow-up (left) computed tomography scan and (right) volume-rendered image.
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over other devices, given the mechanical valve anatomy.
The skills of many subspecialties were used, with
involvement of vascular surgery, echocardiography, inter-
ventional cardiology, cardiac anesthesia, and cardiac sur-
gery. This is the same team approach that has been
successful in transcatheter aortic valve implantation in the
Placement of Aortic Transcatheter Valves (PARTNER)
study.20 Extended antibiotic therapy, with guidance from
infectious disease specialists, was also a key component to
achieving adequate long-term results, with the caveat that
close follow-up will continue to be essential given place-
ment of a prosthetic material in an infected ﬁeld.
CONCLUSIONS
AAPs pose signiﬁcant treatment challenges, particularly
in patients with clinical comorbidities limiting open interven-
tion. Certain technical considerations can guide safe deploy-
ment of ascending aortic stent grafts in these challenging
patients.
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